E.U. Negotiations With Drug Companies Over Potential Coronavirus Vaccines Struggle To Reach Deal, Sources Say

Reuters: Exclusive: E.U. talks with Pfizer, Sanofi, J&J on COVID vaccines hit snags — sources
“European efforts to secure potential COVID-19 vaccines from Pfizer, Sanofi, and Johnson & Johnson are mired in wrangles over price, payment method, and potential liability costs, three E.U. officials told Reuters. … Despite the urgency to seal deals amid a global race to secure the most promising shots, the E.U. is struggling to reach swift agreements, said the officials, who are involved in the talks, and declined to be named because the negotiations are confidential…” (Guarascio et al., 7/27).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.